Description
P.18 Daratumumab therapy in patients with immunoglobulin light chain amyloidosis, a single center experience
Article: P.18 Daratumumab therapy in patients with immunoglobulin light chain amyloidosis, a single center experience
€3.03
€3.03
P.18 Daratumumab therapy in patients with immunoglobulin light chain amyloidosis, a single center experience
Top
Notifications
Reviews
There are no reviews yet.